News

Filter

Current filters:

None

1 to 9 of 97856 results

Amarin in deal with Eddingpharm to commercialize Vascepa in China

Amarin in deal with Eddingpharm to commercialize Vascepa in China

28-02-2015

US biotech firm Amarin has entered into an exclusive agreement for Chinese drugmaker Eddingpharm to develop…

AmarinBiotechnologyCardio-vascularChinaEddingpharmLicensingVascepa

EMA/CHMP backs Roche’s Avastin plus chemotherapy in advanced cervical cancer

EMA/CHMP backs Roche’s Avastin plus chemotherapy in advanced cervical cancer

28-02-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a…

AvastinBiotechnologyEuropeOncologyRegulationRoche

Positive Ph III results from Biogen Idec and SOBI’s Alprolix in pediatric study

Positive Ph III results from Biogen Idec and SOBI’s Alprolix in pediatric study

28-02-2015

US biotech major Biogen Idec and Nordic drugmaker Swedish Orphan Biovitrum have announced positive top-line…

AlprolixBiogen IdecBiotechnologyEuropeHematologyRegulationResearchSobiSwedish Orphan Biovitrum

Three new drugs recommended for approval by EMA/CHMP

Three new drugs recommended for approval by EMA/CHMP

27-02-2015

Three new medicines have been recommended for approval at the February 2015 meeting of the European Medicines…

AmgenEuropeJinarcNephrology and HepatologyNovartisOncologyOtsuka PharmaceuticalPharmaceuticalRegulationRistempaVectibixZykadia

UCB's full-year results

UCB's full-year results "confirm position of strength"

27-02-2015

The 2014 full-year financial results from Belgian drugmaker UCB “confirmed the position of strength”…

BelgiumCimziaFinancialImmunologicalsKeppraNeuproNeurologicalPharmaceuticalUCBVimpat

India plans to impose price controls on medical device makers and distributors

India plans to impose price controls on medical device makers and distributors

27-02-2015

In a major crackdown, India's drug regulator the National Pharmaceutical Pricing Authority has come down…

IndiaPharmaceuticalPricingRegulation

PHARMAC in negotiations over rare disorders medicines

PHARMAC in negotiations over rare disorders medicines

27-02-2015

New Zealand’s Pharmaceutical Management Agency, PHARMAC, is in active negotiations with several suppliers…

FinancialHealthcareNew ZealandPharmaceuticalPricingRare diseases

Former Sanofi chief Christopher Viehbacher joins PureTech

Former Sanofi chief Christopher Viehbacher joins PureTech

27-02-2015

The former chief executive of French pharma major Sanofi Christopher Viehbacher has been appointed to…

BoardroomChristopher ViehbacherPharmaceuticalSanofi

1 to 9 of 97856 results

COMPANY SPOTLIGHT

Menarini

Back to top